🇺🇸 FDA
Pipeline program

Tissue Plasminogen Activator (tPA)

tPADNase 1

Phase 1 small_molecule terminated

Quick answer

Tissue Plasminogen Activator (tPA) for Peritoneal Dialysis is a Phase 1 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Peritoneal Dialysis
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials